story of the week
PET-Guided Omission of Radiotherapy in Early-Stage Unfavourable Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PET-Guided Omission of Radiotherapy in Early-Stage Unfavourable Hodgkin Lymphoma (GHSG HD17): A Multicentre, Open-Label, Randomised, Phase 3 Trial
Lancet Oncol 2021 Feb 01;22(2)223-234, P Borchmann, A Plütschow, C Kobe, R Greil, J Meissner, MS Topp, H Ostermann, J Dierlamm, J Mohm, J Thiemer, M Sökler, A Kerkhoff, M Ahlborn, TV Halbsguth, S Martin, U Keller, S Balabanov, T Pabst, M Vogelhuber, A Hüttmann, M Wilhelm, JM Zijlstra, A Moccia, G Kuhnert, PJ Bröckelmann, B von Tresckow, M Fuchs, B Klimm, A Rosenwald, H Eich, C Baues, S Marnitz, M Hallek, V Diehl, M Dietlein, A EngertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.